How should I describe diffuse hazy attenuation on chest CT consistent with vascular congestion and lacking subpleural sparing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Describing Diffuse Hazy Attenuation Without Subpleural Sparing

Describe this finding as "diffuse ground-glass attenuation" or "diffuse ground-glass opacity (GGO)" with specific notation that there is "no subpleural sparing" or "involvement extends to the pleural surfaces." This terminology is standardized and immediately conveys the pattern to radiologists and clinicians 1, 2.

Core Descriptive Framework

Ground-glass attenuation/opacity is defined as a diffuse homogeneous increase in lung density where bronchial and vascular margins remain visible 1, 2. This distinguishes it from consolidation, where these structures become obscured 2, 3.

When documenting your findings, structure the description as follows:

  • Pattern: "Diffuse ground-glass attenuation" or "diffuse hazy increased attenuation"
  • Distribution: "Bilateral and diffuse" with "no subpleural sparing"
  • Associated findings: Note whether vessels appear normal, enlarged, or compressed within the affected areas 3

Critical Distinction: Vascular vs. Infiltrative Disease

Since you suspect vascular congestion, carefully assess the pulmonary vessel caliber within the areas of ground-glass attenuation 3. This is the key differentiating feature:

Vascular congestion/edema shows:

  • Increased vessel diameter in affected areas
  • Smooth interlobular septal thickening (if present)
  • Central and peripheral distribution without true subpleural sparing
  • Associated findings: enlarged pulmonary arteries (MPA >29mm), cardiomegaly, pleural effusions 4, 3

Infiltrative lung disease shows:

  • Normal or decreased vessel caliber in affected areas
  • May have centrilobular nodules, reticulation, or architectural distortion
  • Variable distribution patterns 1, 5, 3

Specific Terminology for Your Report

Use this exact phrasing: "Diffuse bilateral ground-glass attenuation extending to the pleural surfaces without subpleural sparing, with [normal/increased/decreased] caliber of pulmonary vessels within affected regions, consistent with [vascular congestion/pulmonary edema]" 2, 3.

The absence of subpleural sparing is clinically significant because it helps exclude certain diagnoses. Subpleural sparing is characteristic of nonspecific interstitial pneumonitis (NSIP) and helps distinguish it from usual interstitial pneumonitis 6. When absent, as in your case, it broadens the differential toward processes that affect the entire lung uniformly, including vascular congestion, acute lung injury, or certain diffuse infiltrative processes 1, 5.

Additional Descriptors to Include

Document these features to strengthen diagnostic confidence:

  • Vessel analysis: "Pulmonary vessels appear [prominent/normal] within areas of ground-glass attenuation" 3
  • Septal thickening: If present, note whether it's smooth (favors edema) or irregular (favors fibrosis) 1
  • Air bronchograms: Presence suggests alveolar filling rather than pure interstitial process 7
  • Mosaic attenuation: Absence of this finding helps exclude small airway disease 5

Common Pitfalls to Avoid

Do not use "mosaic attenuation" to describe uniform ground-glass opacity. Mosaic attenuation specifically refers to a patchwork of areas with different attenuation levels, typically seen in hypersensitivity pneumonitis or small airway disease 5. Your description of diffuse hazy attenuation without this patchwork pattern is distinctly different.

Do not confuse ground-glass opacity with consolidation. If you can still see vessel margins, it's ground-glass opacity; if vessels are obscured, it's consolidation 2, 8.

The lack of subpleural sparing combined with preserved vessel visibility and clinical suspicion of vascular congestion creates a specific pattern that should prompt evaluation for cardiac causes, fluid overload, or pulmonary veno-occlusive disease 4.

Related Questions

What does pulmonary opacification on imaging indicate?
What is the significance of ground‑glass opacity with peripheral consolidation in the lung bases?
Can pulmonary fibrosis cause a ground glass appearance on imaging, particularly on high-resolution computed tomography (HRCT) scans?
What does a tree-in-bud pattern on a CT scan indicate and what is the appropriate diagnostic work‑up?
What are the causes of peribronchial ground-glass opacities (GGO)?
What are the differences among the available methylphenidate formulations (immediate‑release, sustained‑release, extended‑release, and transdermal) regarding onset of action, duration of effect, dosing schedule, and clinical use?
What initial fibrate dose should be started for a patient with triglycerides of 715 mg/dL, normal renal function (creatinine clearance > 30 mL/min), and no contraindications?
What are the recommended antibiotic regimens for adult patients with infections caused by Enterococcus faecalis and Enterococcus faecium, including dosing and duration?
Should a pregnancy test be obtained before starting testosterone therapy in a patient assigned female at birth who could be pregnant?
How should I manage sleep, anxiety, and depression in a patient with prolonged grief disorder who has failed multiple antidepressants, discontinued medications for depression, post‑traumatic stress disorder, and anxiety, and has a heart murmur and atrial fibrillation?
What is the appropriate treatment for diverticulitis in a patient taking warfarin?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.